Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Sader

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Journal of Chemotherapy (Florence, Italy)|August 2, 2011
Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003-2009)H S Sader, D J Farrell, R N Jones
Clinics in Laboratory Medicine|June 1, 1995
The use of molecular techniques in the epidemiology and control of infectious diseasesH S Sader, R J Hollis, M A Pfaller
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1995
Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysisH S Sader, R N Jones, M A Pfaller
Diagnostic Microbiology and Infectious Disease|December 1, 1994
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing EnterobacteriaceaeH S Sader, M A Pfaller, R N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 10, 2006
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004)A C Gales, R N Jones, H S Sader
Journal of Chemotherapy (Florence, Italy)|January 15, 2010
Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitalsH S Sader, G J Moet, R N Jones
Diagnostic Microbiology and Infectious Disease|October 1, 1994
Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study GroupR N Jones, H S Sader, M E Erwin
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1992
In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolonesH S Sader, M E Erwin, R N Jones
Journal of Chemotherapy (Florence, Italy)|March 18, 2008
Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?A C Galles, R N Jones, H S Sader
Journal of Clinical Microbiology|July 10, 2004
Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are usedT R Anderegg, R N Jones, H S Sader, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Journal of Chemotherapy (Florence, Italy)|August 2, 2011
Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003-2009)H S Sader, D J Farrell, R N Jones
Clinics in Laboratory Medicine|June 1, 1995
The use of molecular techniques in the epidemiology and control of infectious diseasesH S Sader, R J Hollis, M A Pfaller
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1995
Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysisH S Sader, R N Jones, M A Pfaller
Diagnostic Microbiology and Infectious Disease|December 1, 1994
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing EnterobacteriaceaeH S Sader, M A Pfaller, R N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 10, 2006
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004)A C Gales, R N Jones, H S Sader
Journal of Chemotherapy (Florence, Italy)|January 15, 2010
Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitalsH S Sader, G J Moet, R N Jones
Diagnostic Microbiology and Infectious Disease|October 1, 1994
Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study GroupR N Jones, H S Sader, M E Erwin
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1992
In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolonesH S Sader, M E Erwin, R N Jones
Journal of Chemotherapy (Florence, Italy)|March 18, 2008
Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?A C Galles, R N Jones, H S Sader
Journal of Clinical Microbiology|July 10, 2004
Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are usedT R Anderegg, R N Jones, H S Sader, et al.
Pageof 10